Publicacións nas que colabora con Francisco Blanco García (11)

2024

  1. An exploratory analysis of associations of genetic variation with the efficacy of tocilizumab in severe COVID-19 patients. A pharmacogenetic study based on next-generation sequencing

    Frontiers in Pharmacology, Vol. 15

  2. Genomic data from a pharmacogenetic study based on the efficacy of Tocilizumab in severe COVID-19 patients

    Zenodo

  3. Genomic data from a pharmacogenetic study based on the efficacy of Tocilizumab in severe COVID-19 patients

    Zenodo

  4. Mitonuclear epistasis involving TP63 and haplogroup Uk: Risk of rapid progression of knee OA in patients from the OAI

    Osteoarthritis and Cartilage, Vol. 32, Núm. 5, pp. 526-534

2023

  1. A meta-analysis and a functional study support the influence of mtDNA variant m.16519C on the risk of rapid progression of knee osteoarthritis

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 7, pp. 974-984

2022

  1. Single nucleotide polymorphism genes and mitochondrial DNA haplogroups as biomarkers for early prediction of knee osteoarthritis structural progressors: use of supervised machine learning classifiers

    BMC Medicine, Vol. 20, Núm. 1

  2. mtDNA haplogroup A enhances the effect of obesity on the risk of knee OA in a Mexican population

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Identificación y Anotación Exhaustiva de Variantes Mitocondriales para la Investigación en Osteoartritis

    I+S: Revista de la Sociedad Española de Informática y Salud, Núm. 144, pp. 39-41

  2. Oleate Prevents Palmitate-Induced Mitochondrial Dysfunction in Chondrocytes

    Frontiers in Physiology, Vol. 12

2020

  1. Mitochondrial Genetics and Epigenetics in Osteoarthritis

    Frontiers in Genetics, Vol. 10

2019

  1. Differential Association of Mitochondrial DNA Haplogroups J and H With the Methylation Status of Articular Cartilage: Potential Role in Apoptosis and Metabolic and Developmental Processes

    Arthritis and Rheumatology, Vol. 71, Núm. 7, pp. 1191-1200